BD (Becton, Dickinson and Company), a leading global medical technology company, reached a 75% reduction in GHG emissions in 2018 from a baseline year of 2008, normalized to cost of products sold, well ahead of its 2020 target of 50%. The company is close to its goal of using renewable energy to pow
Read More...
BD (Becton, Dickinson and Company) made progress toward its goal of 25% energy reduction by 2030 (from a 2019 baseline, normalized to cost of products sold), achieving 14% energy reduction in FY 2021, in addition to increasing its investment in on-site renewable energy. The global medical techn
Read More...